![Recursion](/img/default-banner.jpg)
- 89
- 242 358
Recursion
United States
Registrace 26. 06. 2019
Recursion is a clinical-stage TechBio company decoding biology to radically improve lives by industrializing drug discovery, development and beyond through disruptive innovation. Enabling its mission is the Recursion OS, a platform built across diverse technologies that continuously expands one of the world's largest proprietary biological and chemical datasets, the Recursion Data Universe. Recursion leverages sophisticated machine-learning algorithms to distill from its dataset the Recursion Map, a collection of hundreds of billions of searchable inferences across biology and chemistry unconstrained by human bias. By commanding massive experimental scale - up to millions of wet lab experiments weekly - and massive computational scale - owning and operating one of the most powerful supercomputers in the world, Recursion is uniting technology, biology and chemistry to advance the future of medicine.
Learn more at www.recursion.com, or connect on X and LinkedIn
Learn more at www.recursion.com, or connect on X and LinkedIn
How Recursion Uses Imaging Data to Understand Biology
Imran Haque, SVP of AI and Digital Sciences at Recursion, walks us through the treasure trove of data found in images, explaining how we use algorithms to structure pixels, how we are leading discovery in the field, and the massive advances that have been made in training foundation models to make new predictions of promising therapeutic targets.
Some highlights:
• Imaging and algorithms can provide as much or more information than RNA sequencing and cost far less money, so you can run more experiments - and you don’t have to kill the cells to do it.
• With ML foundation models acting as a lever, we only need a small amount of data to perform as well as a much larger set. With areas as vast as chemistry and biology, you want to build as much as you can to break these scale barriers.
• The models - called masked autoencoders - can reconstruct some 75-90% of the images of cells that have been masked .
• Once trained, we use these models to turn an unmasked image into a list of numbers and then match these to the database of images of all the cells we’ve taken in the past to see how similar or different the biology is that is created by different conditions (or perturbations) for those cells..
• This technique - called similarity comparison - is central to our digital maps of biology. It’s how we discovered RBM39 provided a new means to inhibit CDK12, a promising therapeutic target for cancer.
#ai #ml #tech #techbio #chemistry #biology #models
Some highlights:
• Imaging and algorithms can provide as much or more information than RNA sequencing and cost far less money, so you can run more experiments - and you don’t have to kill the cells to do it.
• With ML foundation models acting as a lever, we only need a small amount of data to perform as well as a much larger set. With areas as vast as chemistry and biology, you want to build as much as you can to break these scale barriers.
• The models - called masked autoencoders - can reconstruct some 75-90% of the images of cells that have been masked .
• Once trained, we use these models to turn an unmasked image into a list of numbers and then match these to the database of images of all the cells we’ve taken in the past to see how similar or different the biology is that is created by different conditions (or perturbations) for those cells..
• This technique - called similarity comparison - is central to our digital maps of biology. It’s how we discovered RBM39 provided a new means to inhibit CDK12, a promising therapeutic target for cancer.
#ai #ml #tech #techbio #chemistry #biology #models
zhlédnutí: 306
Video
Inside the Recursion-Exscientia definitive agreement
zhlédnutí 542Před 21 dnem
Chris Gibson and Dave Hallett discuss their shared vision for industry-shifting tech-enabled drug discovery, and how their complementary platforms and approaches can accelerate the discovery of better drugs for patients. Learn more and review important and required disclosure related to this information here: www.globenewswire.com/news-release/2024/08/08/2926843/0/en/Recursion-and-Exscientia-En...
Highlights from Recursion's London Office Opening
zhlédnutí 416Před měsícem
“We came to London to seek the best talent in the world." Recursion co-founder and CEO Chris Gibson Reflecting on the recent opening of our London office, which brought together thought leaders in the techbio space along with partners across the London ecosystem one of the world's top AI hubs. A few of our favorite takeaways: Howard Dawber, deputy mayor of business and growth: “As we say in Lon...
The Largest Supercomputer in Pharma
zhlédnutí 903Před měsícem
Drug discovery is now a technology industry. It used to be that supercomputers were only found in aerospace and engineering. Now, together with NVIDIA, Recursion has built one of the top 35 supercomputers in the world - BioHive-2 - to digitize biological data at a resolution and scale that can rapidly accelerate new discoveries - and new medicines. Although demand for GPUs and supercomputers ha...
The Bayer - Recursion Collaboration
zhlédnutí 550Před 2 měsíci
The Bayer - Recursion collaboration brings together Recursion’s technology-forward and AI-leading emphasis and Bayer’s legacy of drug development. The $1.5B deal announced last October in precision oncology already has one joint project now rapidly advancing to Lead Series nomination and we are on track to complete 25 unique multimodal data packages in Q3 2024. Bayer will be the first beta-user...
Download Day 2024 Full Day
zhlédnutí 2,2KPřed 2 měsíci
Recursion’s Download Day 2024 is the company’s second R&D Day. Sell-side equity research analysts, institutional investors, and investment bankers joined members of Recursion’s executive team and board of directors for an engaging, in-person event at the company’s headquarters in Salt Lake City, Utah. The day consisted of presentations on Recursion’s technology, science, pipeline and partnershi...
Download Day 2024 - State of Recursion (Chris Gibson, Recursion Co-founder & CEO)
zhlédnutí 1,2KPřed 2 měsíci
Recursion's Co-founder & CEO Chris Gibson, PhD presents "State of Recursion" at Download Day 2024. About Recursion: Recursion is a leading clinical stage TechBio company decoding biology to industrialize drug discovery. Central to its mission is the Recursion Operating System (OS), a platform built across diverse technologies that continuously expands one of the world’s largest proprietary biol...
Download Day 2024 - Recursion Operating System (Lina Nilsson, SVP Inception Labs)
zhlédnutí 782Před 2 měsíci
Recursion's SVP of Inception Labs Lina Nilsson, PhD presents on the Recursion Operating System (RecursionOS) at Download Day 2024. About Recursion: Recursion is a leading clinical stage TechBio company decoding biology to industrialize drug discovery. Central to its mission is the Recursion Operating System (OS), a platform built across diverse technologies that continuously expands one of the ...
Download Day 2024 - Preclinical at Recursion (Laura Schaevitz, SVP and Head of Research)
zhlédnutí 663Před 2 měsíci
Recursion's SVP and Head of Research, Laura Schaevitz, PhD presents on Recursion's Preclinical Approach and Programs at Download Day 2024. About Recursion: Recursion is a leading clinical stage TechBio company decoding biology to industrialize drug discovery. Central to its mission is the Recursion Operating System (OS), a platform built across diverse technologies that continuously expands one...
Download Day 2024 - Fireside Chat with Recursion's CMO David Mauro and Dr. Deepak Nijhawan
zhlédnutí 270Před 2 měsíci
Download Day 2024 - Fireside Chat with Recursion's CMO David Mauro and Dr. Deepak Nijhawan
Download Day 2024 - Afternoon Convocation (Najat Khan, Recursion Board of Directors)
zhlédnutí 692Před 2 měsíci
Download Day 2024 - Afternoon Convocation (Najat Khan, Recursion Board of Directors)
Download Day 2024 - Recursion Partnerships, (Matt Kinn, SVP of BD & Corporate Initiatives)
zhlédnutí 389Před 2 měsíci
Download Day 2024 - Recursion Partnerships, (Matt Kinn, SVP of BD & Corporate Initiatives)
Download Day 2024 - Recursion's Clinical Programs (David Mauro, Chief Medical Officer)
zhlédnutí 386Před 2 měsíci
Download Day 2024 - Recursion's Clinical Programs (David Mauro, Chief Medical Officer)
Download Day 2024 - Company & Milestones (Michael Secora, Recursion CFO)
zhlédnutí 245Před 2 měsíci
Download Day 2024 - Company & Milestones (Michael Secora, Recursion CFO)
Download Day 2024 - Fireside Chat: NVIDIA Founder & CEO Jensen Huang and Recursion's Chris Gibson
zhlédnutí 29KPřed 2 měsíci
Download Day 2024 - Fireside Chat: NVIDIA Founder & CEO Jensen Huang and Recursion's Chris Gibson
Women in Leadership Video: Kristen Rushton: Full Video
zhlédnutí 84Před 3 měsíci
Women in Leadership Video: Kristen Rushton: Full Video
Women's Leadership Interview Series: Kristen Rushton
zhlédnutí 75Před 3 měsíci
Women's Leadership Interview Series: Kristen Rushton
Recursion and Valence Labs Hosts Techbio Panel in London
zhlédnutí 509Před 4 měsíci
Recursion and Valence Labs Hosts Techbio Panel in London
Recursion Operating System (OS) Finds Undruggable Targets
zhlédnutí 641Před 5 měsíci
Recursion Operating System (OS) Finds Undruggable Targets
Highlight from Women in Leadership Series: Marie Evangelista.
zhlédnutí 112Před 5 měsíci
Highlight from Women in Leadership Series: Marie Evangelista.
Women in Leadership Interview: Marie Evangelista
zhlédnutí 130Před 5 měsíci
Women in Leadership Interview: Marie Evangelista
Rare Disease Day 2024 at Recursion HQ
zhlédnutí 246Před 5 měsíci
Rare Disease Day 2024 at Recursion HQ
Recursionauts Series - The Impact of TechBio
zhlédnutí 770Před 6 měsíci
Recursionauts Series - The Impact of TechBio
Recursionauts Series: Mike Genin, Ph.D.
zhlédnutí 626Před 6 měsíci
Recursionauts Series: Mike Genin, Ph.D.
Recursion x NVIDIA event at JPM2024 - Fireside Chat with Jensen Huang & Martin Chavez
zhlédnutí 48KPřed 7 měsíci
Recursion x NVIDIA event at JPM2024 - Fireside Chat with Jensen Huang & Martin Chavez
LOWE: An LLM-Orchestrated Workflow Engine for Drug Discovery
zhlédnutí 1,6KPřed 7 měsíci
LOWE: An LLM-Orchestrated Workflow Engine for Drug Discovery
Decoding Biology with Data Abundance | Recursion's Imran Haque, SVP of AI and Digital Sciences
zhlédnutí 1,6KPřed 9 měsíci
Decoding Biology with Data Abundance | Recursion's Imran Haque, SVP of AI and Digital Sciences
Recursionauts Series: Tina Marriott Larson - Shaping the Future at Recursion
zhlédnutí 379Před 9 měsíci
Recursionauts Series: Tina Marriott Larson - Shaping the Future at Recursion